” or “CPN”) in 3Q18 shows total revenue of THB 9,499 mn, a decrease of 15.2% from the same period in the previous year (YoY), and net profit of THB 2,928 mn, a decrease of 51.1% YoY, mainly due to the

previous year as the following details below: 1. Revenue from sales and services increased Baht 926.03 million or 56.92 % from the corresponding period of the previous year, derived mostly from revenue from

decreased by 21% compared to the same period at the previous year. It derived from sales 2 of THB 367 million decreasing by 28% compare to the same period at the previous year and revenue from service of THB

% 19% Financial performance in Q2/2018 Revenues from sales and services of EFORL and its subsidiaries in Q2/2018 was THB 4 7 0 million decreased by 7 % compared to the same period at the previous year

For the three-month period ended September 30, 2019, the Company announces net loss of Baht 29.16 million, compared to a net loss of Baht 29.38 million from the same period of previous year. For the

with previous quarter which has net loss Baht 1,056 million due to net gain on exchange rate. Net loss on exchange rate Baht 485 million of previous quarter turn to net gain on exchange rate in this

baht or 6. 56 percent from the previous year, mainly due to a decrease of drug and medical supply cost since the volume of general patients and social security patients decreased. Besides, the Company

previous quarter. The improvement could be attributed to net interest income which increased by Baht 326 million or 1.27 percent. Net interest margin (NIM) stood at 3.34 percent. Non-interest income also

to 3.39 percent, slightly higher than the previous quarter, and still within the target of 3.2- 3.4 percent. In addition, non-interest income rose Baht 1,125 million, or 7.45 percent over-quarter

million and Baht 255.57 million, respectively. In comparison with the same periods of previous year with the net profit of Baht 116.50 million and Baht 252.06 million, respectively, the net profit for the 3